RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Operating income

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Jun 30, 20251,685+27.69%
Jun 30, 20241,320+16.61%
Jun 30, 20231,132+13.15%
Jun 30, 20221,000+10.69%
Jun 30, 2021904+11.61%
Jun 30, 2020810+39.77%
Jun 30, 2019579+6.91%
Jun 30, 2018542+27.25%
Jun 30, 2017426-0.74%
Jun 30, 2016429+4.82%
Jun 30, 2015409+1.02%
Jun 30, 2014405+14.17%
Jun 30, 2013355+20.52%
Jun 30, 2012294+10.30%
Jun 30, 2011267

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)